[1]
R. Josep, P. Wahidiiyat, P. Trihono, and P. Yanuarso, “Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent”, PI, vol. 52, no. 5, pp. 272-9, Oct. 2012.